/KLAR.ST
KLAR.ST Stock - Klaria Pharma Holding AB (publ.)
Healthcare|Drug Manufacturers - Specialty & GenericSTO
$0.61-0.97%
$0.01 (-0.97%) • Dec 23
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.56
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.72
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.67
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for KLAR.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.60 – $0.62
TARGET (TP)$0.70
STOP LOSS$0.56
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.20
52W High$1.81
52W Low$0.28
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.25M | $8.45M | $5.87M | $6.11M | $7.22M |
| Gross Profit | $2.25M | $8.45M | $5.87M | $-4,853,000 | $-6,212,000 |
| Gross Margin | 100.0% | 100.0% | 100.0% | -79.4% | -86.0% |
| Operating Income | $-31,207,000 | $-31,849,000 | $-54,974,000 | $-50,109,000 | $-48,738,000 |
| Net Income | $-47,750,000 | $-35,784,000 | $-63,774,000 | $-53,534,000 | $-51,439,000 |
| Net Margin | -2124.1% | -423.3% | -1086.8% | -875.9% | -712.5% |
| EPS | $-0.38 | $-0.36 | $-1.10 | $-0.97 | $-1.11 |
Company Overview
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
KLAR.STBeat Rate
0%
Last 1 quarters
Avg Surprise
-27.6%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-0.04
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 26, 2025 | — | $-0.04 | — | — |
Q2 2025 | May 21, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 28, 2025 | — | $-0.11 | — | — |
Q4 2024 | Nov 21, 2024 | — | $-0.06 | — | — |
Q3 2024 | Aug 22, 2024 | — | $-0.11 | — | — |
Q2 2024 | May 16, 2024 | — | $-0.11 | — | — |
Q1 2024 | Mar 1, 2024 | — | $-0.09 | — | — |
Q4 2023 | Nov 24, 2023 | — | $-0.10 | — | — |
Q3 2023 | Aug 25, 2023 | — | $-0.09 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.06 | — | — |
Q1 2023 | Feb 10, 2023 | — | $-0.22 | — | — |
Q4 2022 | Nov 18, 2022 | — | $-0.27 | — | — |
Q3 2022 | Aug 26, 2022 | — | $-0.24 | — | — |
Q2 2022 | May 12, 2022 | — | $-0.37 | — | — |
Q1 2022 | Feb 10, 2022 | $-0.22 | $-0.28 | -27.6% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-0.71 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.29 | — | — |
Q2 2021 | May 21, 2021 | — | $-0.36 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.30 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.26 | — | — |
Latest News
Loading news...
Frequently Asked Questions about KLAR.ST
What is KLAR.ST's current stock price?
Klaria Pharma Holding AB (publ.) (KLAR.ST) is currently trading at $0.61 per share. The stock has moved -0.97% today.
What is the analyst price target for KLAR.ST?
No analyst price targets are currently available for this stock.
What sector is Klaria Pharma Holding AB (publ.) in?
Klaria Pharma Holding AB (publ.) operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the STO exchange.
What is KLAR.ST's market cap?
Klaria Pharma Holding AB (publ.) has a market capitalization of $0.19 billion, making it a small-cap company.
Does KLAR.ST pay dividends?
No, Klaria Pharma Holding AB (publ.) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUC.ST
AcuCort AB
$0.57
Mkt Cap: $0.1B
ALZ.ST
Alzinova AB (publ)
$0.82
Mkt Cap: $0.1B
BRAIN.ST
BrainCool AB (publ)
$0.58
Mkt Cap: $0.1B
ERMA.ST
Enorama Pharma AB (publ)
$2.30
Mkt Cap: $0.2B
INTEG-B.ST
Integrum AB (publ)
$10.06
Mkt Cap: $0.2B
ISOFOL.ST
Isofol Medical AB (publ)
$0.72
Mkt Cap: $0.2B
QLINEA.ST
Q-linea AB (publ)
$22.36
Mkt Cap: $0.1B
SCIB.ST
SciBase Holding AB (publ)
$0.36
Mkt Cap: $0.1B
VIVE.ST
Vivesto AB
$0.14
Mkt Cap: $0.1B
XBRANE.ST
Xbrane Biopharma AB (publ)
$10.88
Mkt Cap: $0.1B
Explore stocks similar to KLAR.ST for comparison